Age at Menopause and Trajectories of Multimorbidity Progression to Mortality: A Multi‐State Analysis of UK Biobank Data
- 4 April 2026
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
Abstract
Objective: To investigate whether age at menopause is associated with the trajectory of multimorbidity progression. Design: A retrospective cohort study. Setting: The UK Biobank. Population: 121 017 postmenopausal women aged 40–69 years with complete baseline and menopausal data. Methods: Cox proportional hazards models were used to explore the associations between menopausal age and both multimorbidity and mortality. Multi‐state models were further employed to evaluate the association of menopausal age with transitions from a health state to the first chronic disease (FCD), to multimorbidity, and to mortality from each state. Main Outcome Measures: Multimorbidity (defined as ≥ 2 of 35 chronic conditions) and mortality. Results: Over a median follow‐up period of 8.6 years, 86 821 women developed the FCD, 42237 multimorbidity, and 10 527 participants died. In the multi‐state models analysis, from health to FCD, compared with women who experienced menopause after age 50 years, the risks increased by 32%, 14%, and 3% among women with premature, early, and relatively early menopause, respectively (HR = 1.32, 95% CI: 1.28–1.36; HR = 1.14, 95% CI: 1.11–1.17; HR = 1.03, 95% CI: 1.01–1.05). Similarly, for the transition from FCD to multimorbidity, the risks increased by 22% (HR = 1.22, 95% CI: 1.17–1.27), 13% (HR = 1.13, 95% CI: 1.09–1.16), and 6% (HR = 1.06, 95% CI: 1.03–1.08), respectively. Conclusions: Earlier menopause was associated with an increased risk of multimorbidity and mortality, mainly affecting two trajectories, from health to FCD and FCD to multimorbidity.Keywords
This publication has 41 references indexed in Scilit:
- The association between primary ovarian insufficiency and increased multimorbidity in a large prospective cohort (Canadian Longitudinal Study on Aging)Fertility and Sterility, 2024
- Association of circadian rest-activity rhythms with cardiovascular disease and mortality in type 2 diabetesDiabetes Research and Clinical Practice, 2023
- Hormone therapy regimens for managing the menopause and premature ovarian insufficiencyBest Practice & Research Clinical Endocrinology & Metabolism, 2021
- Age at menopause and mortality in Taiwan: A cohort analysisMaturitas, 2020
- Estrogens Promote Misfolded Proinsulin Degradation to Protect Insulin Production and Delay DiabetesCell Reports, 2018
- Body mass index and age at natural menopause: an international pooled analysis of 11 prospective studiesEuropean Journal of Epidemiology, 2018
- Age at natural menopause and risk of type 2 diabetes: a prospective cohort studyDiabetologia, 2017
- Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause MortalityJAMA Cardiology, 2016
- Health in middle-aged and elderly women: A conceptual framework for healthy menopauseMaturitas, 2015
- Multiple Chronic Conditions: Prevalence, Health Consequences, and Implications for Quality, Care Management, and CostsJournal of General Internal Medicine, 2007